
Office of Communications
and Public Liaison (OCPL)
Building 31, Room 5C27
31 Center Drive, MSC 2292
Bethesda, MD 20892
Phone: 301-496-1752
nianews3@mail.nih.gov
The CDC has issued new guidelines for hepatitis C testing, focusing on people born during 1945–1965, a population with a disproportionately high prevalence of HCV infection and related disease. CDC is now recommending all baby boomers receive...
The National Institutes of Health today unveiled a new online resource for older drivers and families seeking information on an often sensitive topic: Is it still safe to drive? Developed by the National Institute on Aging (NIA) at NIH and the U.S....
Today’s older Americans enjoy longer lives and better physical function than did previous generations, although, for some, an increased burden in housing costs and rising obesity may compromise these gains, according to a comprehensive federal...
The NIA’s GEMSSTAR – Grants for Early Medical/Surgical Specialists' Transition to Aging Research – program is winning rave reviews for enabling physicians just starting out in their careers to connect their specialty to aging...
Epigenetics, the study of how the environment modifies the way the human gene is expressed, is an emerging frontier in science. Diet and exposure to environmental chemicals, among other factors, can cause epigenetic changes that may turn on or off...
The deadline for applications has been extended until August 10th for Taking the Next Step: Grants Technical Assistance Workshop. The workshop is an interactive forum for pre- and post-doctoral students and recent recipients of Ph.D., M.D., or...
Registration is now open for “Unveiling the NIH Toolbox,” a free scientific conference to be held September 10-11 in Bethesda, Maryland. The meeting will present the NIH Toolbox for Assessment of Neurological and Behavioral Function— a set of brief...
The NIA Grants for Early Medical/Surgical Specialists’ Transition to Aging Research (GEMSSTAR) program provides research grant support to early-stage physicians seeking to bridge their clinical specialty with aging research. This program...
On July 12, all of the seats in the Masur Auditorium were filled for the meeting of the NIA’s Geroscience Interest Group (GSIG), a newly formed trans-NIH interest group focused on the premise that aging biology is at the base of many of the...
Posiphen, a drug candidate designed and developed by researchers in the NIA’s Intramural Research Program, has been shown in three small, early studies to be well-tolerated and to reduce the generation of amyloid and tau protein—the...